Y Mabs Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $110k | 6.7k | 16.26 |
| 2023-12-31 | $41k | 6.0k | 6.83 |
| 2023-09-30 | $95 | 19 | 5.00 |
| 2023-03-31 | $235k | 47k | 5.01 |
| 2022-12-31 | $5.2k | 1.1k | 4.88 |
| 2022-09-30 | $1.7M | 94k | 18.18 |
| 2021-12-31 | $1.1M | 68k | 16.21 |
| 2021-03-31 | $3.2M | 97k | 33.06 |
| 2020-12-31 | $407k | 8.1k | 50.00 |
| 2020-09-30 | $143k | 3.4k | 41.67 |
| 2020-06-30 | $694k | 17k | 40.65 |
| 2020-03-31 | $432k | 17k | 26.14 |
| 2019-12-31 | $549k | 18k | 31.25 |
| 2019-09-30 | $34k | 1.3k | 26.25 |
| 2019-06-30 | $150k | 6.5k | 22.91 |
| 2019-03-31 | $49k | 1.9k | 26.14 |
| 2018-12-31 | $37k | 1.8k | 20.02 |